Assessing the potential of RNA-based therapeutics for a group of Lysosomal Storage Diseases with neurological involvement

During the first two decades of the 21st century, remarkable progresses have been achieved in the field of RNA-based therapeutics. From antisense RNA to RNA modification, the therapeutic potential of RNA-based technologies has nothing but increased. In our lab, we have been addressing the potential...

ver descrição completa

Detalhes bibliográficos
Autor principal: Santos, Juliana Inês (author)
Outros Autores: Gonçalves, Mariana (author), Matos, Liliana (author), Gaspar, Paulo (author), Pires, Maria João (author), Oliveira, Paula (author), Prata, Maria João (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2022
Assuntos:
Mucopolysaccharidosis III
Lysosomal Storage Diseases
Doenças Lisossomais de sobrecarga
Mucopolissacaridose III
Doenças Genéticas
Genética Humana
Texto completo:http://hdl.handle.net/10400.18/7990
País:Portugal
Oai:oai:repositorio.insa.pt:10400.18/7990

Texto Completo

http://hdl.handle.net/10400.18/7990

Registros relacionados